Univest
Univest
  • Markets
  • Anlon Healthcare Analyst Review 2027: Revenue Doubles and H1 Beats All of FY26

    • November 19, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Anlon Healthcare Analyst Review 2027: Revenue Doubles and H1 Beats All of FY26

    Anlon Healthcare roughly doubled Q2 FY27 revenue to ₹105.61 crore and grew profit about 84% to ₹17.18 crore, with H1 revenue already above FY26’s total. With no verified brokerage target, we review results, guidance, cash flow, valuation and risks.

    read more